![Frontiers | Antibiotic resistance of Helicobacter pylori isolated from patients in Nanjing, China: A cross-section study from 2018 to 2021 Frontiers | Antibiotic resistance of Helicobacter pylori isolated from patients in Nanjing, China: A cross-section study from 2018 to 2021](https://www.frontiersin.org/files/MyHome%20Article%20Library/970630/970630_Thumb_400.jpg)
Frontiers | Antibiotic resistance of Helicobacter pylori isolated from patients in Nanjing, China: A cross-section study from 2018 to 2021
![High dose PPI-amoxicillin dual therapy for the treatment of Helicobacter pylori infection: a systematic review with meta-analysis - Yang-Jie Zhu, Yi Zhang, Ting-Yi Wang, Jing-Tao Zhao, Zhe Zhao, Jian-Ru Zhu, Chun-Hui Lan, High dose PPI-amoxicillin dual therapy for the treatment of Helicobacter pylori infection: a systematic review with meta-analysis - Yang-Jie Zhu, Yi Zhang, Ting-Yi Wang, Jing-Tao Zhao, Zhe Zhao, Jian-Ru Zhu, Chun-Hui Lan,](https://journals.sagepub.com/cms/10.1177/1756284820937115/asset/images/large/10.1177_1756284820937115-fig1.jpeg)
High dose PPI-amoxicillin dual therapy for the treatment of Helicobacter pylori infection: a systematic review with meta-analysis - Yang-Jie Zhu, Yi Zhang, Ting-Yi Wang, Jing-Tao Zhao, Zhe Zhao, Jian-Ru Zhu, Chun-Hui Lan,
![Fourteen-day sequential therapy is superior to 7-day triple therapy as first-line regimen for Helicobacter pylori infected children - ScienceDirect Fourteen-day sequential therapy is superior to 7-day triple therapy as first-line regimen for Helicobacter pylori infected children - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0929664621001066-gr1.jpg)
Fourteen-day sequential therapy is superior to 7-day triple therapy as first-line regimen for Helicobacter pylori infected children - ScienceDirect
![Helicobacter pylori treatment in the post-antibiotics era—searching for new drug targets | SpringerLink Helicobacter pylori treatment in the post-antibiotics era—searching for new drug targets | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00253-020-10945-w/MediaObjects/253_2020_10945_Fig1_HTML.png)
Helicobacter pylori treatment in the post-antibiotics era—searching for new drug targets | SpringerLink
![Microorganisms | Free Full-Text | Factors Affecting the Intraluminal Therapy for Helicobacter pylori Infection Microorganisms | Free Full-Text | Factors Affecting the Intraluminal Therapy for Helicobacter pylori Infection](https://www.mdpi.com/microorganisms/microorganisms-10-00415/article_deploy/html/images/microorganisms-10-00415-g001.png)
Microorganisms | Free Full-Text | Factors Affecting the Intraluminal Therapy for Helicobacter pylori Infection
![PDF] Helicobacter pylori treatment in Turkey: Current status and rational treatment options | Semantic Scholar PDF] Helicobacter pylori treatment in Turkey: Current status and rational treatment options | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/0ee571ad5e7d0017b56c012ab6d1e567706caa26/3-Table2-1.png)
PDF] Helicobacter pylori treatment in Turkey: Current status and rational treatment options | Semantic Scholar
What's the best secondary treatment for patients who fail initial triple therapy for H pylori? | MDedge Family Medicine
![Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective ... Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective ...](https://journals.asm.org/cms/10.1128/AAC.00432-18/asset/76813d3f-4a51-4793-abb8-e9f6b357b642/assets/graphic/zac0091874060001.jpeg)
Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective ...
![Susceptibility of Helicobacter Pylori to Antibiotics: a Study of Prevalence in Patients with Dyspepsia in Quito, Ecuador Susceptibility of Helicobacter Pylori to Antibiotics: a Study of Prevalence in Patients with Dyspepsia in Quito, Ecuador](http://www.scielo.org.co/img/revistas/rcg/v32n4//0120-9957-rcg-32-04-00305-gt4.png)